Future Medicinal Chemistry

Papers
(The H4-Index of Future Medicinal Chemistry is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
The role of descriptors extracted from ligand-target interaction to improve conventional QSAR model performance in the realm of angiogenesis receptor modulation to fight cancer68
The Connection Between PARP14 and SARS-CoV-266
Development of 5-hydroxybenzothiophene derivatives as multi-kinase inhibitors with potential anti-cancer activity62
Novel Set of Highly Substituted Bis-Pyridines: Synthesis, Molecular Docking and Drug-Resistant Antibacterial Profile50
In vivo evaluation of novel synthetic pyrazolones as CDK9 inhibitors with enhanced pharmacokinetic properties42
α-Glucosidase-targeting 1,2,4-triazole antidiabetic candidates: comparative analysis and future perspectives42
Design and synthesis of new nicotinamides as immunomodulatory VEGFR-2 inhibitors and apoptosis inducers32
Hybridization of isatin and benzoxazolinone via a diethyl spacer: a new scaffold for breast cancer drug discovery29
Biological and computational evaluation of novel benzofuranyl derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors29
Therapeutic potential of spirocyclopropyl oxindoles: latest developments in drug discovery28
Synthesis of thiosemicarbazone derivatives of thiophene-2-carboxylic acid as potent urease inhibitors: in vitro evaluation, molecular docking, and densit27
Small molecule dual inhibitors of HDAC6/HSP90 as potential anticancer therapeutics: an overview of design rationality and structure activity relationships27
Small-molecule Cathepsin K inhibitors: a medicinal chemistry perspective25
Butenolide-based human carbonic anhydrase (hCA) I/II inhibitors: integrated computational and biological evaluation25
Synergistic effect of new pyrimidine derivative with oxacilin against methicillin-resistant Staphylococcus aureus25
Basic nitrogen (BaN): a ‘privileged element’ in medicinal chemistry25
Investigations of New N 1 -Substituted Pyrazoles as Anti-Inflammatory and Analgesic Agents having COX Inhibitory Act25
New pyrrolopyridine-based Thiazolotriazoles As Diabetics Inhibitors: Enzymatic Kinetics and In Silico Study24
Advances in AR-Targeting Chimeras: A Case Study of proteolysis-targeting Chimeras From Bench to Bedside24
Wogonin-derived chemotype enables discovery of novel GLS1 inhibitors with potent antitumor activity23
Key heterocyclic moieties for the next five years of drug discovery and development22
Design, synthesis and inhibition evaluation of novel chalcone amide α-glucosidase inhibitors22
0.081033945083618